The Senate Health, Education, Labor and Pensions Committee today held a hearing for Alex Azar, President Trump’s nominee for secretary of Health and Human Services. Azar, former president of Lilly USA and deputy HHS secretary under the George W. Bush administration, faced a number of questions from senators about his ties to the pharmaceutical industry and how he would tackle high drug prices. “I believe I can bring the skills and experiences to the table that can help us address these issues, while still encouraging discovery so Americans have access to high quality care,” Azar said. Trump nominated Azar for HHS secretary earlier this month. Tom Price, M.D., resigned as HHS secretary on Sept. 29. Deputy Secretary Eric Hargan has been serving as acting secretary. Azar will need to testify before the Senate Finance Committee, which has not announced a hearing date, before the full Senate votes on his appointment.

Related News Articles

Perspective
Hospital and health system leaders work hard to ensure their organizations can deliver high-quality care, comply with evolving regulations, embrace…
Headline
AHA President and CEO Rick Pollack this week received the ASHP Award of Honor, which recognizes individuals outside the pharmacy discipline who have made…
Headline
President-elect Donald Trump Nov. 14 announced that he has selected Robert F. Kennedy Jr. to lead the Department of Health and Human Services.
Headline
The AHA Nov. 7 announced Claire M. Zangerle, DNP, R.N., as new senior vice president and chief nurse executive of the AHA and chief executive officer of its…
Headline
In this conversation, Michelle Schweitzer, N.P., executive director of advanced practice providers at WakeMed, discusses the growing role her APP colleagues…
Headline
The Indiana Hospital Association Oct. 29 announced Scott Tittle as its new president. Tittle is a former managing director of VIUM Capital, a long-term care…